The economic impact of machine perfusion technology in liver transplantation.
暂无分享,去创建一个
I. Brüggenwirth | R. Porte | V. D. de Meijer | B. Domínguez-Gil | A. Hessheimer | M. Perera | A. C. Boteon | Y. Boteon | P. Martins | M. Padilla
[1] S. Knight,et al. A systematic review and meta‐analyses of regional perfusion in donation after circulatory death solid organ transplantation , 2021, Transplant international : official journal of the European Society for Organ Transplantation.
[2] R. Porte,et al. Hypothermic Machine Perfusion in Liver Transplantation. Reply. , 2021, The New England journal of medicine.
[3] A. M. Shapiro,et al. Cost‐utility analysis of normothermic machine perfusion compared to static cold storage in liver transplantation in the Canadian setting , 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[4] D. Paredes,et al. Consensus statement on normothermic regional perfusion in donation after circulatory death: Report from the European Society for Organ Transplantation’s Transplant Learning Journey , 2021, Transplant international : official journal of the European Society for Organ Transplantation.
[5] José Luis Bernal,et al. Improved short‐term outcomes of kidney transplants in controlled donation after the circulatory determination of death with the use of normothermic regional perfusion , 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[6] R. Jalan,et al. A Call for Randomization in Clinical Trials of Liver Machine Perfusion Preservation , 2020, Hepatology.
[7] M. Mengel,et al. Industry partnerships in transplantation: How should AJT manage the inevitable conflict of interest? , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[8] B. Meunier,et al. Hypothermic Oxygenated Perfusion Improves Extended Criteria Donor Liver Graft Function and Reduces Duration of Hospitalization Without Extra Cost: The PERPHO Study , 2020, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[9] A. M. Shapiro,et al. The Actual Operative Costs of Liver Transplantation and Normothermic Machine Perfusion in a Canadian Setting , 2020, PharmacoEconomics - Open.
[10] I. Brüggenwirth,et al. Viability criteria assessment during liver machine perfusion , 2020, Nature Biotechnology.
[11] Rachel M. Brown,et al. NAPLES STUDY (NORMOTHERMIC MACHINE PERFUSION OF THE LIVER TO ENABLE THE SICKEST FIRST): PRELIMINARY RESULTS , 2020 .
[12] D. Chang,et al. Viability testing of discarded livers with normothermic machine perfusion: Alleviating the organ shortage outweighs the cost , 2020, Clinical transplantation.
[13] M. Javanbakht,et al. Cost-utility analysis of normothermic liver perfusion with the OrganOx metra compared to static cold storage in the United Kingdom , 2020, Journal of medical economics.
[14] S. Curbishley,et al. Transplantation of discarded livers following viability testing with normothermic machine perfusion , 2020, Nature Communications.
[15] C. Nickson,et al. When Should Clinicians Act on Non-Statistically Significant Results From Clinical Trials? , 2020, JAMA.
[16] F. Tacke,et al. Ischemia-Reperfusion Injury in Marginal Liver Grafts and the Role of Hypothermic Machine Perfusion: Molecular Mechanisms and Clinical Implications , 2020, Journal of clinical medicine.
[17] Rachel J. Johnson,et al. Donation after circulatory death today: an updated overview of the European landscape , 2020, Transplant international : official journal of the European Society for Organ Transplantation.
[18] Sita J. Saunders,et al. Critical Review of European Health-Economic Guidelines for the Health Technology Assessment of Medical Devices , 2019, Front. Med..
[19] P. Parrilla,et al. Reply to: "Normothermic regional perfusion - What is the benefit?" , 2019, Journal of hepatology.
[20] H. Yeh,et al. Increasing Donor Liver Utilization Through Machine Perfusion , 2019, Hepatology.
[21] R. Bhogal,et al. Manipulation of Lipid Metabolism During Normothermic Machine Perfusion: Effect of Defatting Therapies on Donor Liver Functional Recovery , 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[22] C. Fondevila,et al. Normothermic perfusion and outcomes after liver transplantation. , 2019, Transplantation reviews.
[23] R. Porte,et al. Evolving Trends in Machine Perfusion for Liver Transplantation. , 2019, Gastroenterology.
[24] P. Parrilla,et al. Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation. , 2019, Journal of hepatology.
[25] N. Heaton,et al. Study protocol for a multicenter randomized controlled trial to compare the efficacy of end-ischemic dual hypothermic oxygenated machine perfusion with static cold storage in preventing non-anastomotic biliary strictures after transplantation of liver grafts donated after circulatory death: DHOPE-DC , 2019, BMC Gastroenterology.
[26] P. Marchetti,et al. Pilot, Open, Randomized, Prospective Trial for Normothermic Machine Perfusion Evaluation in Liver Transplantation From Older Donors , 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[27] T. Kerforne,et al. Defining the optimal duration for normothermic regional perfusion in the kidney donor: A porcine preclinical study , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[28] M. Nijsten,et al. Transplantation of High-risk Donor Livers After Ex Situ Resuscitation and Assessment Using Combined Hypo- and Normothermic Machine Perfusion: A Prospective Clinical Trial. , 2019 .
[29] R. Porte,et al. Ex situ machine perfusion strategies in liver transplantation. , 2019, Journal of hepatology.
[30] R. Bhogal,et al. Combined Hypothermic and Normothermic Machine Perfusion Improves Functional Recovery of Extended Criteria Donor Livers , 2018, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[31] N. Heaton,et al. A randomized trial of normothermic preservation in liver transplantation , 2018, Nature.
[32] S. Afford,et al. Pushing the Limits: Machine Preservation of the Liver as a Tool to Recondition High-Risk Grafts , 2018, Current Transplantation Reports.
[33] C. Coussios,et al. The case for normothermic machine perfusion in liver transplantation , 2018, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[34] C. Watson,et al. From “Gut Feeling” to Objectivity: Machine Preservation of the Liver as a Tool to Assess Organ Viability , 2018, Current Transplantation Reports.
[35] B. Suberviola,et al. Improving the Outcomes of Organs Obtained From Controlled Donation After Circulatory Death Donors Using Abdominal Normothermic Regional Perfusion , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[36] M. Casado,et al. Cost-effectiveness analysis of two treatment strategies for chronic hepatitis C before and after access to direct-acting antivirals in Spain. , 2017, Gastroenterologia y hepatologia.
[37] C. Fondevila,et al. Hypothermic or normothermic abdominal regional perfusion in high‐risk donors with extended warm ischemia times: impact on outcomes? , 2015, Transplant international : official journal of the European Society for Organ Transplantation.
[38] J. O'donnell. Personalized medicine and the role of health economics and outcomes research: issues, applications, emerging trends, and future research. , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[39] P. Clavien,et al. Protective mechanisms of end-ischemic cold machine perfusion in DCD liver grafts. , 2013, Journal of hepatology.
[40] Katherine Payne,et al. Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest group. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[41] G. Meyer,et al. Two hundred years of hospital costs and mortality--MGH and four eras of value in medicine. , 2012, The New England journal of medicine.
[42] M. Kinkhabwala,et al. Hypothermic Machine Preservation in Human Liver Transplantation: The First Clinical Series , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[43] M. Manyalich,et al. The Effect of Normothermic Recirculation is Mediated by Ischemic Preconditioning in NHBD Liver Transplantation , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[44] J. Visa,et al. HEPATIC XANTHINE LEVELS AS VIABILITY PREDICTOR OF LIVERS PROCURED FROM NON-HEART-BEATING DONOR PIGS1 , 2001, Transplantation.